We highlight new diagnostic results of a known ITD event on exon 13 of upstream binding transcription factor (UBTF) that has recently been characterized as a novel prognostic genetic variation in AML, particularly in relapse cases (Umeda et al. 2022). The gene discussed is UBTF; the disease is acute myeloid leukemia.